›› 2008, Vol. 28 ›› Issue (6): 367-371.

• 论文 • 上一篇    下一篇

小鼠IFN-γ基因的克隆及其分子佐剂作用的研究

  

  1. 中国农业大学动物医学院,北京 100094
  • 收稿日期:2008-04-11 出版日期:2008-06-30 发布日期:2008-06-30

Cloning of Murine IFN-Y and its Effect as a Molecular Adjuvant

  1. College of Animal Medicine, China Agriculture University, Beijing 100193, China
  • Received:2008-04-11 Online:2008-06-30 Published:2008-06-30

摘要: 目的 通过融合表达小鼠IFN-γ(MuIFN-γ)与猪脑心肌炎病毒(EMCV)结构蛋白VP1研究MuIFN-γ的分子佐剂作用。方法 通过RT-PCR克隆IFN-γ的成熟肽基因,从pGEX-6p-1/vp1中亚克隆猪脑心肌炎病毒(EMCV)抗原基因VP1,分别构建原核表达菌株pET32-a/VP1/Rosetta(DE3)和pET32-a/VP1/MuIFN-γ,将VP1及VP1与MuIFN-γ在宿主菌Rosetta(DE3)中进行表达与共表达。将表达的VP1及MuIFN-γ/VP1蛋白分别免疫BALB/c小鼠,每次免疫2周后采血,分离血清,利用ELISA测定抗体效价。结果 表达的VP1蛋白分子量为60kD,共表达蛋白MuIFN-γ/VP1分子量为73kD,VP1及MuIFN-γ/VP1蛋白免疫小鼠测定的抗体效价分别为1:32000和1:128000。结论 表达的VP1蛋白具有良好的免疫原性,可刺激免疫小鼠产生明显的体液免疫反应。MuIFN-γ/VP1免疫小鼠后产生的佐剂效果要强于弗氏佐剂。MuIFN-γ/VP1蛋白能增强小鼠的体液免疫水平,MuIFN-γ具有一定的分子佐剂效应。

关键词: MuIFN-γ, EMCVVP1, 原核表达, 免疫佐剂

Abstract: Objective Study the molecular adjuvant effect of MuIFN-T by co-expressing MuIFN-T and EMCV structural protein VP1. Method Mature peptide gene of MuIFN-T was cloned by using RT-PCR. VP1 of pig EMCV was subcloned from pGEX-6p-l/vpl, and constructed into the express plasmid pET32-a /VPl/Rosetta(DE3) and co-expression plasmid pET32-a/VPl/MuIFN-T, respectively. BALB/c mice were inoculated with the VP1 and VIuIFN-Y/VPl proteins in 'E.coli, respectively, for three times at two week intervals, serum IgG were detected by ELISA every two weeks post-inoculation. Result In Ecoli Rosetta(DE3), expression and co-expression were succeeded IPTG (Isopropyl β-D-l-Thiogalactopyranoside) induction, with 60 MW of VP1 protein and 73 MW of co-expressed protein. The serum IgG of mice post-inoculated by VP1 and MuIFN-T/VP 1 are 1 : 32000 and 1 : 128000. Conclusions VP1 had good antigenicity which could stimulated humoral immune response in inoculated mice, the detected serum IgG of MuIFN-γ/VP 1 inoculation is higher than VP1. Moreover, immune enhancing effects was found in mice inoculated with co-expressed MuIFN-T/VPl .LMuIFN-T was a satisfactory immune adjuvant.

Key words: MuIFN-γ, EMCV VP1, Prokaryotic expression, Immune adjuvant